Atlas Trials

Addition of Modulators of Homocysteine to Adalimumab Therapy in the Treatment of Moderate to Severe Plaque Psoriasis

Clinical trial NCT01704599 · TERMINATED

Trial details

NCT number
NCT01704599
Sponsor
Wayne State University
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Psoriasis
Start date
2009-01-01
Primary completion
2013-06-01
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.